CellWell record HH-237251
Lipoprotein(a) in cardiovascular disease: pathophysiology, residual risk, and emerging therapeutic strategies
Lucio Giuseppe Granata; Simona Giubilato; Francesca Campanella; Francesco Amico; Stefania Angela Di Fusco; Furio Colivicchi
2026
In plain language
Lipoprotein(a) is a genetically determined risk factor for atherosclerotic cardiovascular disease unresponsive to lifestyle and poorly controlled by statins, but RNA therapeutics targeting hepatic LPA expression reduce levels by 80-90%.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-237251
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.